HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lymphoproliferative disorders in four patients receiving chronic diphenylhydantoin therapy: etiologic correlation or chance association?

Abstract
The occurrence of angioimmunoblastic lymphadenopathy, Hodgkin's disease or IgG-lambda multiple myeloma is described in four patients receiving chronic diphenylhydantoin (DILANTIN) therapy. Although the association between diphenylhydantoin therapy and the development of immunosuppression and lymphoma is well documented, the role of the drug in the etiology of these disorders is still controversial. It is suggested that periodic examination of patients receiving diphenylhydantoin for lymphadenopathy and repeated serum electrophoresis may be useful in detecting early aberrations of the immune system in these individuals.
AuthorsY Matzner, A Polliack
JournalIsrael journal of medical sciences (Isr J Med Sci) Vol. 14 Issue 8 Pg. 865-9 (Aug 1978) ISSN: 0021-2180 [Print] Israel
PMID700999 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Phenytoin
Topics
  • Adult
  • Female
  • Hodgkin Disease (chemically induced)
  • Humans
  • Immunoblastic Lymphadenopathy (chemically induced)
  • Lymphoproliferative Disorders (chemically induced)
  • Male
  • Middle Aged
  • Multiple Myeloma (chemically induced)
  • Phenytoin (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: